GAITHERSBURG, Md., July 13, 2020 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it […]
Caris to provide DNA and RNA molecular testing to support patient identification and enrollment for Merus’ Zenocutuzumab Phase 1/2 eNRGy trialUTRECHT, […]
Companies have ongoing collaboration in first-line metastatic triple-negative breast cancerImmunomedics also announces Phase 2 NeoSTAR study in neoadjuvant triple-negative breast […]